Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Amarin Corporation plc (AMRN)

1.44   -0.05 (-3.36%) 07-02 19:48
Open: 1.46 Pre. Close: 1.49
High: 1.49 Low: 1.2
Volume: 10,869,076 Market Cap: 572(M)
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.49 - 1.5 1.5 - 1.51
Low: 1.18 - 1.19 1.19 - 1.2
Close: 1.42 - 1.44 1.44 - 1.45

Technical analysis

as of: 2022-07-01 4:20:01 PM
Overall:       
Stoxline posted a SELL today, upgraded from strong sell. Downward movement continues, but could change at any time.
Target: Six months: 2     One year: 2.37
Support: Support1: 1.2    Support2: 0.99
Resistance: Resistance1: 1.71    Resistance2: 2.02
Pivot: 1.78
Moving Average: MA(5): 1.7     MA(20): 1.78
MA(100): 2.5     MA(250): 3.6
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 28.9     %D(3): 43.1
RSI: RSI(14): 34.9
52-week: High: 5.96  Low: 1.11
Average Vol(K): 3-Month: 4,911 (K)  10-Days: 4,207 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ AMRN ] has closed below the lower bollinger band by 9.1%. Bollinger Bands are 31.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sat, 02 Jul 2022
Amarin (NASDAQ:AMRN) Rating Lowered to Sell at StockNews.com - Defense World

Fri, 01 Jul 2022
Why Amarin Stock Is Sinking Today - The Motley Fool

Fri, 24 Jun 2022
Do Analysts Expect Amarin Corporation plc (AMRN) Stock to Rise After It Has Risen 43.38% in a Month? - InvestorsObserver

Wed, 15 Jun 2022
Sarissa Capital Intends to Vote “Abstain” at the Amarin Annual Meeting - Business Wire

Tue, 14 Jun 2022
Amarin Beats Investor Bid to Revive Heart Disease Drug Dispute - Bloomberg Law

Fri, 10 Jun 2022
How Will the Market React to Amarin Corporation plc (AMRN) Stock Getting a Neutral Rating - InvestorsObserver

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 396 (M)
Shares Float 345 (M)
% Held by Insiders 1.2 (%)
% Held by Institutions 36.1 (%)
Shares Short 18,090 (K)
Shares Short P.Month 16,490 (K)

Stock Financials

EPS -0.02
EPS Est Next Qtl -0.03
EPS Est This Year -0.21
EPS Est Next Year -0.06
Book Value (p.s.) 1.62
Profit Margin (%) 1.3
Operating Margin (%) 4.1
Return on Assets (ttm) 1.4
Return on Equity (ttm) 1.1
Qtrly Rev. Growth -13.7
Gross Profit (p.s.) 1.16
Sales Per Share 1.47
EBITDA (p.s.) 0.06
Qtrly Earnings Growth 305.8
Operating Cash Flow -67 (M)
Levered Free Cash Flow 70 (M)

Stock Valuations

PE Ratio -130.91
PEG Ratio -0.2
Price to Book value 0.88
Price to Sales 0.97
Price to Cash Flow -8.57

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.